Physician

Aamer Farooq, MD

According to 2025 Medicare claims, Aamer Farooq, MD (NPI: 1518165919) practices hematology/oncology in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Middlesex, NJ. This provider's primary affiliated billing organization is TITAN HEALTH PARTNERS LLC (NPI: 1790396281; TIN: 852303328) and primary practice location at 08816-3340. Farooq is affiliated with the Physician Leaders Direct Contracting Entity, LLC (ACO ID: D0171) and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under the REACH model.

Farooq's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 481 traditional Medicare patients, billed 19,659 HCPCS/CPT codes, and received $445,362 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 794 prescription claims across 152 beneficiaries totaling $1,856,968 in drug costs, led by Neulasta (Pegfilgrastim). DME data shows 12 claims. Open Payments data shows 32 records totaling $10,029. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $144,766 to $445,362. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $554,147 and ending at $1,856,968. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $551 to $2,103.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$812K$1.6M2015 Medicare payment: $144,766 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $164,485 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $107,037 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $924,653 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,138,837 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,624,384 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $768,149 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,146,804 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,370,127 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $445,362 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20154806,596$144,766
20165808,637$164,485
20175641,943$107,037
201841896,720$924,653
2019401139,884$1,138,837
2020385128,235$1,624,384
202144070,161$768,149
202240684,487$1,146,804
202354591,478$1,370,127
202448119,659$445,362

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.1M$2.1M2015 Drug cost: $554,147 (USD; Tot_Drug_Cst)2016 Drug cost: $1,055,409 (USD; Tot_Drug_Cst)2017 Drug cost: $2,140,197 (USD; Tot_Drug_Cst)2018 Drug cost: $993,091 (USD; Tot_Drug_Cst)2019 Drug cost: $761,248 (USD; Tot_Drug_Cst)2020 Drug cost: $1,258,963 (USD; Tot_Drug_Cst)2021 Drug cost: $569,686 (USD; Tot_Drug_Cst)2022 Drug cost: $495,238 (USD; Tot_Drug_Cst)2023 Drug cost: $833,908 (USD; Tot_Drug_Cst)2024 Drug cost: $1,856,968 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151991,134$554,147
20162361,287$1,055,409
20172702,049$2,140,197
2018190810$993,091
20191641,035$761,248
20201971,141$1,258,963
2021151597$569,686
202286597$495,238
2023115512$833,908
2024152794$1,856,968

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$7.5K$15K2015 Medicare payment: $15,050 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $10,720 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $4,437 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $764 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $4,392 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $226 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R12$15,050
2016N/RN/RN/R
2017N/R42$10,720
2018N/R35$4,437
2019N/R22$764
2020N/R24$4,392
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/R12$226

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes127151$143
99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes137165$110
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more190491$98
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes2461,369$66
36415Insertion of needle into vein for collection of blood sample121274$9

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
NeulastaPegfilgrastim27686$280,776
AranespDarbepoetin Alfa In Polysorbat661,610$206,482
XtandiEnzalutamide13390$178,601
PromactaEltrombopag Olamine12360$158,701
OntruzantTrastuzumab-Dttb16336$61,555

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day periodNN/R12$226

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.32$10,029Astellas Pharma US Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Aamer Farooq, MD?

Tedicare shows public-source Medicare data for Aamer Farooq, MD (NPI 1518165919), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aamer Farooq, MD have ACO affiliation data?

Aamer Farooq, MD is shown with ACO affiliation data for Physician Leaders Direct Contracting Entity, LLC (REACH, ACO ID D0171) and Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Aamer Farooq, MD?

Aamer Farooq, MD is linked to TITAN HEALTH PARTNERS LLC (billing NPI 1790396281) in the available physician profile data.

Does Aamer Farooq, MD have Open Payments data?

Aamer Farooq, MD has 32 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.